Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it means for Eli Lilly's future growth.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Lilly invests $3 billion to expand Wisconsin plant
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Drugmaker Eli Lilly plans to invest $3 billion to expand a manufacturing facility in the Kenosha County, Wis., to meet growing demand for its diabetes and weight-loss medicines.
Eli Lilly Invests $3B to Expand Wisconsin Factory to Help Meet Demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars
Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.
1h
Eli Lilly’s $3 billion expansion in Kenosha County will mean 750 new jobs
Eli Lilly has announced a $3 billion expansion in Kenosha County to its manufacturing facility acquired earlier this year in ...
4h
on MSN
Lilly's Zepbound will first be given in the UK to those with 'highest clinical need'
The initial rollout of Eli Lilly's weight loss drug Zepbound in the UK will first go to those with the great clinical need ...
Yahoo Finance
9h
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials
Eli
Lilly
(NYSE:LLY) has been making headlines recently with its weight-loss drug
Zepbound
(tirzepatide).
Eli
Lilly
...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Tsunami warnings lifted
French government falls
Fox News commentator dies
Images of suspect released
Congress halts Ukraine aid
May cut diabetes risk
US telecom firms hacked
Recuses himself from case
Nadler to step aside
Independent run for gov.
Theriault ends recount
Medellin cartel leader freed
MX record fentanyl bust
Leaded gas health risk
Tops $100K for the first time
Billy Long to lead IRS
DOJ: Bias against Blacks
Rockefeller tree lights up
Composer Laird dies at 85
Winter storm to hit US
Social Security chief pick
Raw milk recall expands
Recalls over 205,000 SUVs
SpaceX sets record
$10B AI data center in LA
US trade deficit shrinks
Airlines to pay for delays?
Weekly jobless claims rise
Taiwan's pres visits Guam
Syrian rebels capture Hama
Prenatal test spots cancer?
Delays oil output hike
Satellites to create eclipses
New AI tools for employees
Related topics
Wegovy
Novo Nordisk
Amgen
Glucagon-like peptide-1
Feedback